Hellix Ventures HLLXF, Global Entertainment Holdings GBHL | Today’s Penny Stock Report

Global Entertainment Holdings Inc. GBHL

Yesterday, GBHL woke up and traded ten times its average daily volume. The stock opened at .14, and subsequently hit a high of .20 before dipping back to .103, and closing out the day strong at .15.

 There a few highlights on the GBHL chart that we have pointed out below. A rising RSI, coupled with an impending Golden Cross, and increasing volume, leaves us feeling bullish on this stock.

We feel that GBHL is just starting to break out of its shell, and granted that this is our first mention of the play, it seems that we arrived just in the nick of time to observe an exciting period of trading for the stock.

Hellix Ventures Inc. HLLXF

HLLXF dipped to as low as a 1.38 on Wednesday, and managed to close at its high of day of 1.65, for a 20% intraday gain, and an overall 10% gain on the day. We also like to see a stock close with some momentum, an occurrence which is often indicative of continued activity.

The stock traded 2 1/2 its three month average volume as well, another good sign moving forward.

We are always eager to participate in mining plays, especially with the market conditions being so favorable with respect to precious metals.

UTRM | United Treatment Centers, Inc. | News Out | 09/06/11

UTRM is moving again today, on the strength this morning’s press:

United Treatment Centers, Inc. Enters Into Letter of Intent to Acquire Nature’s Instincts, Inc.

NEW YORK, NY, Sep 06, 2011 (MARKETWIRE via COMTEX) — United Treatment Centers, Inc. (PINKSHEETS: UTRM) announced today that the company has entered into a Letter of Intent to acquire Houston-based Nature’s Instincts, Inc.

Pending the completion of full due diligence by both entities, the transaction is anticipated to be completed during the last half of September 2011.

Mr. Richard M. Johnson, CEO of Nature’s Instincts, Inc., stated, “This is an ideal merger for both parties. This will allow both companies to facilitate their business plans and allowed for a unified front making both units stronger than they were before the merger.”

Mr. Frank Ottaviani, CEO of United Treatment Centers Inc., said, “We look forward to completing this merger and creating a stronger entity upon closing. The proven track record of Nature’s Instincts Stemulite product line and the newly improved Stemulite II will only enhance United Treatment Center’s footprint on the retail market.”

About Nature’s Instincts, Inc. Nature’s Instincts has acquired a proprietary patent-pending platform of all natural health products based on a core technology derived from stem cell research. The products are comprised of a series of natural plant extracts and other natural components with a wide array of properties, all of which benefit from their unique abilities to better integrate the product’s advantages into human cell structure and work on the body’s own stem cells. Natures Instincts, Inc. offers a total of seven products. They are Stemulite II AM for men, Stemulite II PM for men, Stemulite II AM for women, Stemulite II PM for women, ProStem II, SominaPM and AlertNRG. Nature’s Instincts’ platform of products are all-natural and have no known negative side effects and are non-addictive. For more information visit: http://www.naturesinstincts.com/.